Continuous subcutaneous insulin infusion-an opportunity for better care but not a "magic pill"
Endocrine
.
2017 Apr;56(1):4-6.
doi: 10.1007/s12020-016-1217-x.
Epub 2016 Dec 30.
Authors
Avivit Cahn
1
2
,
Eytan Roitman
3
,
Genya Aharon-Hananel
4
,
Itamar Raz
5
Affiliations
1
The Diabetes Unit, Hadassah University Hospital, Jerusalem, Israel.
2
Endocrinology and Metabolism Unit, Hadassah University Hospital, Jerusalem, Israel.
3
Endocrinology, Diabetes and Metabolism Institute, Meir Medical Center, Kfar Saba, Israel.
4
Ichilov Medical Center, Internal Medicine Department T and the Diabetes Medical Center, Tel Aviv-Yafo, Israel.
5
The Diabetes Unit, Hadassah University Hospital, Jerusalem, Israel. ntv502@netvision.net.il.
PMID:
28039560
DOI:
10.1007/s12020-016-1217-x
No abstract available
Publication types
Editorial
Comment
MeSH terms
Diabetes Mellitus, Type 1*
Humans
Insulin
Insulin Infusion Systems
Substances
Insulin